Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Echinococcus multilocularis | hexokinase type 2 | 0.0085 | 0.3217 | 0.2614 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0041 | 0.0816 | 0.0816 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0072 | 0.2523 | 0.1859 |
Brugia malayi | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Leishmania major | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1474 | 0.1474 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2087 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0072 | 0.2523 | 0.5 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0072 | 0.2523 | 0.1859 |
Trypanosoma brucei | trypanothione reductase | 0.0208 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0072 | 0.2523 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0072 | 0.2523 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0072 | 0.2523 | 0.2499 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0072 | 0.2523 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0068 | 0.2306 | 0.2306 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0072 | 0.2523 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Echinococcus multilocularis | dna polymerase eta | 0.0068 | 0.2306 | 0.1622 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Brugia malayi | Hexokinase family protein | 0.0053 | 0.1481 | 0.1481 |
Plasmodium falciparum | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Brugia malayi | hexokinase type II | 0.0027 | 0.004 | 0.004 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0083 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0053 | 0.1471 | 0.1471 |
Loa Loa (eye worm) | hexokinase type II | 0.0085 | 0.3217 | 0.3217 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0072 | 0.2523 | 0.2499 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.004 | 0.004 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0072 | 0.2523 | 0.1859 |
Echinococcus granulosus | hexokinase type 2 | 0.0085 | 0.3217 | 0.2614 |
Leishmania major | trypanothione reductase | 0.0208 | 1 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0072 | 0.2523 | 0.2499 |
Toxoplasma gondii | thioredoxin reductase | 0.0208 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.1474 | 0.1474 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0041 | 0.0816 | 0.028 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0552 | 0.0552 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Leishmania major | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Brugia malayi | Thioredoxin reductase | 0.0208 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0208 | 1 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0072 | 0.2523 | 0.2499 |
Entamoeba histolytica | hexokinase 2 | 0.0085 | 0.3217 | 1 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0072 | 0.2523 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.004 | 0.0749 | 0.0719 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.2306 | 0.2306 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Plasmodium falciparum | thioredoxin reductase | 0.0208 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.004 | 0.004 |
Plasmodium falciparum | thioredoxin reductase | 0.0072 | 0.2523 | 0.2499 |
Leishmania major | DNA polymerase eta, putative | 0.004 | 0.0749 | 0.0719 |
Toxoplasma gondii | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Schistosoma mansoni | DNA polymerase eta | 0.0068 | 0.2306 | 0.1857 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0208 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0072 | 0.2523 | 0.2523 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Plasmodium vivax | glutathione reductase, putative | 0.0208 | 1 | 1 |
Echinococcus granulosus | geminin | 0.018 | 0.8469 | 0.8333 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0072 | 0.2523 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0208 | 1 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0072 | 0.2523 | 0.1859 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.1474 | 0.1474 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.004 | 0.0749 | 0.0719 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Echinococcus granulosus | dna polymerase eta | 0.0068 | 0.2306 | 0.1622 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0083 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1736 | 0.1736 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0072 | 0.2523 | 1 |
Plasmodium vivax | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Echinococcus multilocularis | geminin | 0.018 | 0.8469 | 0.8333 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0041 | 0.0816 | 0.028 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0072 | 0.2523 | 0.2499 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0041 | 0.0816 | 0.0816 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.1859 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0208 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Treponema pallidum | hexokinase (hxk) | 0.0085 | 0.3217 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0208 | 1 | 1 |
Entamoeba histolytica | hexokinase 1 | 0.0085 | 0.3217 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0072 | 0.2523 | 0.2499 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0552 | 0.0552 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0072 | 0.2523 | 0.5 |
Loa Loa (eye worm) | glutathione reductase | 0.0208 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0053 | 0.1481 | 0.1481 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.1859 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.8469 | 0.838 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Brugia malayi | Hexokinase family protein | 0.0085 | 0.3217 | 0.3217 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0053 | 0.1471 | 0.1471 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Schistosoma mansoni | hexokinase | 0.0085 | 0.3217 | 0.2821 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0208 | 1 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.1474 | 0.1474 |
Plasmodium falciparum | glutathione reductase | 0.0072 | 0.2523 | 0.2499 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.8469 | 0.838 |
Trypanosoma brucei | unspecified product | 0.0041 | 0.0816 | 0.0786 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0208 | 1 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0072 | 0.2523 | 0.2499 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0.0000124 % | Measurement of binding affinity by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus | ChEMBL. | 7902439 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.